Case Report
Copyright ©The Author(s) 2021.
World J Clin Cases. Apr 6, 2021; 9(10): 2259-2267
Published online Apr 6, 2021. doi: 10.12998/wjcc.v9.i10.2259
Table 1 Patient electrolyte and hormone profile
Parameter
First visit
Follow-up (after 1 yr)
Reference range
Serum sodium, mmol/L138140135-145
Serum potassium, mmol/L3.824.383.50-5.30
Serum chloride, mmol/L102.9103.9137-147
Serum calcium, mmol/L2.402.402.20-2.65
Serum phosphorus, mmol/L1.361.400.81-1.45
Serum magnesium, mmol/L0.780.800.77-1.03
Follicle stimulating hormone, mIU/mL60.8660.833.50-12.50
Luteinizing hormone, mIU/mL19.9823.882.40-12.60
Estradiol, pg/mL< 5.0011.9612.40-233.00
Progesterone, ng/mL0.1010.7220.00-0.89
Testosterone, ng/mL0.2000.3100.025-0.481
Free testosterone, pg/mL3.484.120.00-4.20
17Hydroxyprogesterone, ng/mL (first time)24.7027.260.05-1.02
17Hydroxyprogesterone, ng/mL (second time)12.10-0.05-1.02
Dehydroepiandrosterone, μg/dL4.154.774.30-22.40
Androstenedione, ng/mL7.128.180.30-3.30
Adrenocorticotropic hormone, pg/mL39.7451.067.20-63.30
Cortisol (8:00), nmol/L15.3213.201.65-9.23
Cortisol (16:00), nmol/L4.96-3.44-16.76
Cortisol (0:00), nmol/L1.83--
AMH, ng/mL< 0.06--
Table 2 Human chorionic gonadotropin stimulation test results
Parameter
0 min
24 h
48 h
72 h
Testosterone, ng/mL0.2500.3000.2600.290
Androstenedione, mmol/L8.18--4.86
Dihydrotestosterone35.59--28.90